Coripharma is a European generic pharmaceutical company specializing in technically challenging products that require specialized expertise. We take an opportunistic approach to portfolio development, focusing on high-value generics where development barriers create market opportunities.
Our experienced team manages formulation development and manufacturing in our Icelandic facility, delivering quality dossiers and reliable supply to out-licensing partners across Europe.
While Coripharma is a relatively new brand, our team brings decades of pharmaceutical development expertise. Our reputation for tackling difficult projects stems from Iceland's strong tradition of pharmaceutical innovation and our strategic focus on products that demand specialized capabilities.
